Fecal occult blood screening participation
1 paper1 finding
- 1 lab in 1 country
- Human trial1
Outcomes
1Colorectal cancer mortality
downin humans1RR 0.57
1 study
Colorectal cancer mortality
downin humans1RR 0.57
Fecal occult blood screening participation decreases colorectal cancer mortality in humans (RR 0.57 (95% CI, 0.40-0.80), 43% reduction).
“After further adjustment for nonadherence in the SG (196 deaths) and participation in the CG (82 deaths), the RR for participation was 0.57 (95% CI, 0.40-0.80)”
Humansadjusted for contamination and nonadherencen = 376,511
Fecal Occult Blood Screening Outcomes Adjusted for Contamination Bias and Nonadherence
JAMA network open3 Aug 2026
Latest
1 in 12 monthsJAMA Network Open
Fecal Occult Blood Screening Outcomes Adjusted for Contamination Bias and Nonadherence
Cohort study of 376,511 peopleInterventions